Open AccessChronic cluster‐like headache in a patient with a macroprolactinoma presenting with falsely low prolactin levels: bromocriptine versus cabergoline?
Author(s) -
Pineyro Maria M.,
Sosa Gabriela,
Finozzi Maria R.,
Stecker Natalia,
Pisabarro Raul,
Belzarena Maria C.
Publication year - 2017
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.1208
Subject(s) - cabergoline , medicine , bromocriptine , prolactin , headaches , hyperprolactinaemia , cluster headache , prolactinoma , acromegaly , migraine , endocrinology , surgery , growth hormone , hormone
Key Clinical Message Cluster‐like headache may be associated with pituitary tumors, mostly prolactinomas. Pituitary imaging and prolactin measurement should be assessed in patients presenting with cluster‐like headaches with atypical features or unsatisfactory response to treatment. Furthermore, large pituitary adenomas with moderate increase in prolactin levels should prompt prolactin dilutions to avoid “hook effect”.